Shiv Sena (UBT) MP Sanjay Raut has formally accused Maharashtra Food and Drugs Administration (FDA) officials of running an extortion racket targeting hotels and quick-commerce firms. The allegations suggest that officials are demanding bribes to restore suspended licenses, raising concerns about the regulatory environment and the cost of doing business for retailers and food service operators in the state.
Sanjay Raut, a Rajya Sabha MP from the Shiv Sena (UBT), has submitted a formal complaint to Maharashtra Food and Drugs Administration (FDA) Commissioner Tukaram Mundhe, accusing the department of operating an extortion racket. The allegations suggest that officials are leveraging their inspection powers to demand bribes from businesses, particularly targeting hotels and the quick-commerce sector.
According to the complaint, these regulatory actions are often based on flimsy grounds, such as unverified social media reports rather than documented violations. Raut contends that when businesses face sudden license suspensions, they are then forced to pay to get these licenses restored. The letter claims that the unofficial cost for resolving these closing notices has reportedly risen significantly, from Rs 10,000 to figures between Rs 75,000 and Rs 2 lakh, allegedly circulating among FDA officers in areas like Bandra and Thane.
For investors and business owners, the regulatory environment in a state like Maharashtra is a key factor in operational continuity. The quick-commerce sector, which relies on a network of hyper-local dark stores, is particularly sensitive to sudden disruptions. Even a temporary suspension of a license can halt local deliveries, impact revenue, and create supply chain bottlenecks. While the FDA’s primary mandate is to ensure public health and food safety, any deviation from transparent enforcement—if the allegations were proven true—would represent a significant operational risk for companies operating in the state.
Raut has requested a high-level, independent inquiry into these enforcement practices. He is specifically pushing for greater transparency, asking that the department disclose the formal reasons behind any license suspension, details of the subsequent hearings, and the logic behind reinstatements. While Commissioner Tukaram Mundhe has previously spoken about improving the department’s system, Raut argues that these efforts are currently undermined by alleged internal corruption that leaves entrepreneurs feeling vulnerable.
Investors tracking companies with large footprints in Maharashtra—such as major retail chains, food-service operators, and quick-commerce players—should note that regulatory scrutiny is a standard part of doing business. However, the key monitorable will be the official response from the FDA or the state government. A formal investigation or a change in the transparency of inspection protocols would be a significant development. If the claims lead to a more rigid or, conversely, a more transparent oversight process, it could alter how businesses manage their compliance reporting in the state. For now, the situation remains a matter of public allegation, and stakeholders will be watching for official updates or any government-mandated procedural audits.